These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23397675)

  • 21. Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice.
    Zanichelli A; Maurer M; Aberer W; Caballero T; Longhurst HJ; Bouillet L; Fabien V; Andresen I;
    Allergy; 2017 Jun; 72(6):994-998. PubMed ID: 27926986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Icatibant: HOE 140, JE 049, JE049.
    Drugs R D; 2004; 5(6):343-8. PubMed ID: 15563238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment options for idiopathic angioedema.
    Shroba J; Hanson J; Portnoy J
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):429-33. PubMed ID: 26341649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Upper airway obstruction caused by ACE inhibitor-induced angioedema].
    Kongstad T; Islander G
    Lakartidningen; 2012 Apr 4-10; 109(14-15):758-61. PubMed ID: 22611881
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
    Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant.
    Antonen J; Leppänen I; Tenhunen J; Arvola P; Mäkelä S; Vaheri A; Mustonen J
    Scand J Infect Dis; 2013 Jun; 45(6):494-6. PubMed ID: 23294035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDMA-induced angioedema treated with icatibant.
    Escalante FA; Del Baño F; Supervía A
    Clin Toxicol (Phila); 2015; 53(10):1148-9. PubMed ID: 26479353
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid resolution of erythema marginatum after icatibant in acquired angioedema.
    Bygum A; Broesby-Olsen S
    Acta Derm Venereol; 2011 Mar; 91(2):185-6. PubMed ID: 21279303
    [No Abstract]   [Full Text] [Related]  

  • 29. The early treatment of bradykinin angioedema, a challenge for emergency medicine.
    Javaud N; Lapostolle F; Sapir D; Dubrel M; Adnet F; Fain O
    Eur J Emerg Med; 2013 Aug; 20(4):291-2. PubMed ID: 23154214
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of acquired angioedema with icatibant: a case report.
    Zanichelli A; Badini M; Nataloni I; Montano N; Cicardi M
    Intern Emerg Med; 2011 Jun; 6(3):279-80. PubMed ID: 20680518
    [No Abstract]   [Full Text] [Related]  

  • 31. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
    Zanichelli A; Bova M; Coerezza A; Petraroli A; Triggiani M; Cicardi M
    Allergy; 2012 Aug; 67(8):1074-7. PubMed ID: 22686628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
    Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A
    Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial.
    Baş M
    Expert Rev Clin Immunol; 2012 Nov; 8(8):707-17. PubMed ID: 23167682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary angioedema].
    Bouilland O; Schoenlaub P
    Rev Prat; 2012 Jan; 62(1):26. PubMed ID: 22335061
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
    Schmidt PW; Hirschl MM; Trautinger F
    J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347
    [No Abstract]   [Full Text] [Related]  

  • 36. Letter in response to "MDMA-induced angioedema treated with icatibant".
    Wilkerson RG; Hayes BD
    Clin Toxicol (Phila); 2016 Mar; 54(3):293. PubMed ID: 26817391
    [No Abstract]   [Full Text] [Related]  

  • 37. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.
    Bouillet L; Boccon-Gibod I; Ponard D; Drouet C; Cesbron JY; Dumestre-Perard C; Monnier N; Lunardi J; Massot C; Gompel A
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):448. PubMed ID: 19927548
    [No Abstract]   [Full Text] [Related]  

  • 38. MDMA-induced angioedema treated with icatibant.
    Supervía A; Del Baño F
    Clin Toxicol (Phila); 2016 Mar; 54(3):294. PubMed ID: 26857700
    [No Abstract]   [Full Text] [Related]  

  • 39. [Emergency management of acute angioedema].
    Bas M; Greve J; Bier H; Knopf A; Stark T; Schuler P; Hoffmann TK; Kojda G
    Dtsch Med Wochenschr; 2010 May; 135(20):1027-31. PubMed ID: 20461661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema.
    Drake D
    Emerg Med J; 2011 Aug; 28(8):720-1. PubMed ID: 21788245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.